Expected to advocate automated quality control (QC) technologies as a means of minimizing contamination risk, the long-awaited European Union (EU) good manufacturing practice (GMP) Annex 1 poses a variety of potential compliance challenges for makers of sterile pharmaceuticals in both Europe and the United States. Will you be ready?
Prepare yourself for the future with this wide-ranging preview, outlining key regulatory issues concerning automation. Helpful links to a broad cross-section of industry analyses are included for additional reference.
Fill out the form to get your copy today.